TOP 30 Cancer biotechnology in Greenlawn, New York

3 results found

Philip Schulman, MD is a doctor specializing in health located at 5 Cuba Hill Road, Greenlawn, New York, United States. Dr. Schulman is a member of the faculty at the Icahn School of Medicine at Mount Sinai, where physicians and scientists collaborate with pharmaceutical, device, biotechnology companies, and other entities to improve patient care and develop new therapies. Dr. Schulman has not yet completed reporting of industry relationships, but Mount Sinai promotes transparency and ethical conduct in all research, clinical care, and teaching activities. Patients are encouraged to inquire about any potential collaborations with outside companies. For more information on Mount Sinai's policies regarding faculty collaboration with industry, please visit our website.

Welcome to the practice of Dr. Ashutosh (Ash) K. Tewari, MBBS, MCh, FRCS (Hon), located at 5 Cuba Hill Road, Greenlawn, New York. Dr. Tewari is a distinguished urologist and prostate cancer specialist, currently serving as the Chairman of the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai. With an impressive career, Dr. Tewari has performed over 5,000 robotic radical prostatectomy surgeries, making his case series one of the largest globally and establishing his outcomes as the gold standard in the field. Dr. Tewari is dedicated to advancing prostate cancer treatment through his leadership at the Tewari Lab, where groundbreaking research into the genomic causes of prostate cancer is underway. His work translates genomic insights into practical applications for physicians, leveraging advanced imaging techniques. Recognized for his contributions, Dr. Tewari received the prestigious American Urological Association’s Gold Cystoscope Award in 2012.

Welcome to the practice of Michael Gorin, MD, where exceptional urologic care meets cutting-edge research and innovation. Conveniently located at 5 Cuba Hill Road, Greenlawn, New York, Dr. Gorin is a highly esteemed Associate Professor in the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai. He specializes in treating a wide range of urologic conditions, including enlarged prostate symptoms, kidney stones, kidney tumors, and prostate cancer. As a fellowship-trained endourologist, Dr. Gorin offers the most advanced minimally invasive treatment options to his patients. Dr. Gorin is not only a skilled surgeon but also a pioneering clinical researcher. He is renowned for his work in molecular imaging for diagnosing and managing urologic malignancies. Notably, he was part of the first clinical team to explore PSMA-targeted PET imaging with PYLARIFY, leading to its FDA approval. This breakthrough imaging technique has since benefited countless prostate cancer patients.